ZBH

As of July 27, 2026, Zimmer Biomet Holdings, Inc. has a market capitalization of $18.0 billion, making it a large-cap company in the Healthcare sector.

Of the 42 analyst ratings on Zimmer Biomet Holdings, Inc., 40% are Buy or Strong Buy, 22 are Hold, and 3 are Sell. The overall consensus rating is Hold. Analyst ratings are opinions, not investment advice.

The average analyst price target for Zimmer Biomet Holdings, Inc. is $92.86. Individual targets range from $83.00 to $105.00.

Zimmer Biomet Holdings, Inc. is scheduled to report earnings on August 5, 2026. Analysts expect earnings of $2.01 per share.

Yes — Zimmer Biomet Holdings, Inc. has paid $0.96 per share in dividends over the trailing twelve months.

ZBH has a beta of 0.46, meaning it has historically been less volatile than the broader market.

Zimmer Biomet Holdings, Inc. operates in the Healthcare sector, the Medical - Devices industry, and its stock trades on NYSE.